ImageneBio (IMA) Other Accumulated Expenses (2020 - 2024)

Historic Other Accumulated Expenses for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to $1.2 million.

  • ImageneBio's Other Accumulated Expenses fell 8037.46% to $1.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.2 million, marking a year-over-year decrease of 8037.46%. This contributed to the annual value of $4.0 million for FY2023, which is 1116.09% down from last year.
  • As of Q3 2024, ImageneBio's Other Accumulated Expenses stood at $1.2 million, which was down 8037.46% from $843000.0 recorded in Q2 2024.
  • ImageneBio's 5-year Other Accumulated Expenses high stood at $6.1 million for Q3 2023, and its period low was $843000.0 during Q2 2024.
  • For the 5-year period, ImageneBio's Other Accumulated Expenses averaged around $2.9 million, with its median value being $2.4 million (2021).
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first surged by 20395.19% in 2022, then crashed by 8037.46% in 2024.
  • Over the past 5 years, ImageneBio's Other Accumulated Expenses (Quarter) stood at $2.3 million in 2020, then increased by 10.57% to $2.5 million in 2021, then soared by 79.27% to $4.5 million in 2022, then decreased by 11.16% to $4.0 million in 2023, then tumbled by 69.6% to $1.2 million in 2024.
  • Its last three reported values are $1.2 million in Q3 2024, $843000.0 for Q2 2024, and $2.3 million during Q1 2024.